MAPK3 and non-small cell lung carcinoma: Recently, AIM2 has been also shown to support extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation and activation independently of the inflammasome in non-small cell lung cancer (NSCLC) cells [43].